October 10, 2020
Stem Cell Transplant for MDS
Stem Cell Transplant for MDS
This webinar will provide an overview of the epidemiology of MDS. Risk Assessment, IPSS-R Prognostic Risk Categories, Allogeneic HCT will be discussed.
Speaker
JM
Joseph P. McGuirk, DO
Our Supporters
Thank you to Bristol-Myers Squibb, Novartis, Jazz Pharmaceuticals, Takeda Oncology, and Acceleron for supporting this initiative.
